Navigate this market better. Subscribe for FREE stock alerts and information.

Thursday, July 31, 2014

Valeant says on hunt for more deals, including contact lenses, (NYSE: AGN), (NYSE: VRX), (TSE: VRX.TO)

Valeant Pharmaceuticals International Inc on Thursday said it remains on the hunt for other companies, including makers of innovative contact lenses, as it presses on with efforts to take over Botox-maker Allergan Inc . On a conference call with investors, Valeant Chief Executive Officer Michael Pearson said the company will not be content to remain the No. 4 global player in the contact lens industry.Valeant officials said Allergan shareholders would profit more through a merger with Toronto-based Valeant than remaining a standalone company.The company said Allergan shareholders would receive about twice as much cash earnings per share - meaning profits adjusted for one-time items - in 2016 with a merged company, than if Allergan were to remain independent.

Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN fell by 3.02% or $-5.2/share to $166.97. In the past year, the shares have traded as low as $86.95 and as high as $174.49. On average, 2963100 shares of AGN exchange hands on a given day and today's volume is recorded at 1326084.

Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 6.97% or $-8.77/share to $117.06. In the past year, the shares have traded as low as $91.00 and as high as $153.10. On average, 3052760 shares of VRX exchange hands on a given day and today's volume is recorded at 3318940.

Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 7.21% or $-9.91/share to $127.51. In the past year, the shares have traded as low as $97.00 and as high as $170.45. On average, 322241 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 221512.



Source